Plain-English translation of NCT03938701 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new way to visualize how โ a modified version of a common inflammation medication โ spreads through inflamed areas in your body. Researchers will use special near-infrared fluorescence imaging (similar to how thermal cameras work) to see where the medication goes and how it concentrates in inflamed tissues. This could help doctors better understand how the medication works and potentially improve treatment in the future.
Currently, doctors have to guess whether an inflammation medication is reaching the right spots in your body. This study aims to create a better way to actually see and measure where the treatment goes, which could lead to more personalized and effective care for inflammatory bowel disease and rheumatoid arthritis.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will receive an injection of the study medication at different doses (depending on which group you're assigned to), and then researchers will use special imaging cameras to track where it goes in your body over time. If you have inflammatory bowel disease, you'll have imaging done during or around your already-scheduled colonoscopy. If you have rheumatoid arthritis, the imaging will focus on your inflamed joints. The entire process involves hospital or clinic visits where you'll undergo these painless imaging scans.
AI-generated summary from trial data ยท Jun 14, 2026 ยท Not medical advice
Netherlands